169 related articles for article (PubMed ID: 24642699)
1. Biocompatible KMnF3 nanoparticular contrast agent with proper plasma retention time for in vivo magnetic resonance imaging.
Liu ZJ; Song XX; Xu XZ; Tang Q
Nanotechnology; 2014 Apr; 25(15):155101. PubMed ID: 24642699
[TBL] [Abstract][Full Text] [Related]
2. Development of PEGylated KMnF3 nanoparticles as a T1-weighted contrast agent: chemical synthesis, in vivo brain MR imaging, and accounting for high relaxivity.
Liu ZJ; Song XX; Tang Q
Nanoscale; 2013 Jun; 5(11):5073-9. PubMed ID: 23640287
[TBL] [Abstract][Full Text] [Related]
3. Fabrication and evaluation of tumor-targeted positive MRI contrast agent based on ultrasmall MnO nanoparticles.
Huang H; Yue T; Xu K; Golzarian J; Yu J; Huang J
Colloids Surf B Biointerfaces; 2015 Jul; 131():148-54. PubMed ID: 25982318
[TBL] [Abstract][Full Text] [Related]
4. Mn(2+)-doped silica nanoparticles for hepatocyte-targeted detection of liver cancer in T1-weighted MRI.
Kim SM; Im GH; Lee DG; Lee JH; Lee WJ; Lee IS
Biomaterials; 2013 Nov; 34(35):8941-8. PubMed ID: 23973173
[TBL] [Abstract][Full Text] [Related]
5. Mesoporous NaYbF4@NaGdF4 core-shell up-conversion nanoparticles for targeted drug delivery and multimodal imaging.
Zhou L; Zheng X; Gu Z; Yin W; Zhang X; Ruan L; Yang Y; Hu Z; Zhao Y
Biomaterials; 2014 Aug; 35(26):7666-78. PubMed ID: 24929618
[TBL] [Abstract][Full Text] [Related]
6. Lactoferrin-conjugated superparamagnetic iron oxide nanoparticles as a specific MRI contrast agent for detection of brain glioma in vivo.
Xie H; Zhu Y; Jiang W; Zhou Q; Yang H; Gu N; Zhang Y; Xu H; Xu H; Yang X
Biomaterials; 2011 Jan; 32(2):495-502. PubMed ID: 20970851
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Motexafin gadolinium (MGd) as a contrast agent for intraoperative MRI.
Hirschberg H; Wu GN; Madsen SJ
Minim Invasive Neurosurg; 2007 Dec; 50(6):318-23. PubMed ID: 18210352
[TBL] [Abstract][Full Text] [Related]
8. T1-T2 dual-modal MRI of brain gliomas using PEGylated Gd-doped iron oxide nanoparticles.
Xiao N; Gu W; Wang H; Deng Y; Shi X; Ye L
J Colloid Interface Sci; 2014 Mar; 417():159-65. PubMed ID: 24407672
[TBL] [Abstract][Full Text] [Related]
9. Magnetic PEGylated Pt3Co nanoparticles as a novel MR contrast agent: in vivo MR imaging and long-term toxicity study.
Yin S; Li Z; Cheng L; Wang C; Liu Y; Chen Q; Gong H; Guo L; Li Y; Liu Z
Nanoscale; 2013 Dec; 5(24):12464-73. PubMed ID: 24165858
[TBL] [Abstract][Full Text] [Related]
10. A novel gadolinium-based trimetasphere metallofullerene for application as a magnetic resonance imaging contrast agent.
Adiseshaiah P; Dellinger A; MacFarland D; Stern S; Dobrovolskaia M; Ileva L; Patri AK; Bernardo M; Brooks DB; Zhou Z; McNeil S; Kepley C
Invest Radiol; 2013 Nov; 48(11):745-54. PubMed ID: 23748228
[TBL] [Abstract][Full Text] [Related]
11. MnO nanoparticles with unique excitation-dependent fluorescence for multicolor cellular imaging and MR imaging of brain glioma.
Lai J; Wang T; Wang H; Shi F; Gu W; Ye L
Mikrochim Acta; 2018 Apr; 185(4):244. PubMed ID: 29610993
[TBL] [Abstract][Full Text] [Related]
12. Brain tumor enhancement in magnetic resonance imaging at 3 tesla: intraindividual comparison of two high relaxivity macromolecular contrast media with a standard extracellular gd-chelate in a rat brain tumor model.
Fries P; Runge VM; Bücker A; Schürholz H; Reith W; Robert P; Jackson C; Lanz T; Schneider G
Invest Radiol; 2009 Apr; 44(4):200-6. PubMed ID: 19300099
[TBL] [Abstract][Full Text] [Related]
13. Hydrothermally synthesized PEGylated calcium phosphate nanoparticles incorporating Gd-DTPA for contrast enhanced MRI diagnosis of solid tumors.
Mi P; Kokuryo D; Cabral H; Kumagai M; Nomoto T; Aoki I; Terada Y; Kishimura A; Nishiyama N; Kataoka K
J Control Release; 2014 Jan; 174():63-71. PubMed ID: 24211705
[TBL] [Abstract][Full Text] [Related]
14. Bio-inspired, melanin-like nanoparticles as a highly efficient contrast agent for T1-weighted magnetic resonance imaging.
Ju KY; Lee JW; Im GH; Lee S; Pyo J; Park SB; Lee JH; Lee JK
Biomacromolecules; 2013 Oct; 14(10):3491-7. PubMed ID: 23987128
[TBL] [Abstract][Full Text] [Related]
15. Melanin-manganese nanoparticles with ultrahigh efficient clearance in vivo for tumor-targeting T
Xu W; Sun J; Li L; Peng X; Zhang R; Wang B
Biomater Sci; 2017 Dec; 6(1):207-215. PubMed ID: 29210372
[TBL] [Abstract][Full Text] [Related]
16. High relaxivities and strong vascular signal enhancement for NaGdF4 nanoparticles designed for dual MR/optical imaging.
Naccache R; Chevallier P; Lagueux J; Gossuin Y; Laurent S; Vander Elst L; Chilian C; Capobianco JA; Fortin MA
Adv Healthc Mater; 2013 Nov; 2(11):1478-88. PubMed ID: 23666643
[TBL] [Abstract][Full Text] [Related]
17. Development of a dendritic manganese-enhanced magnetic resonance imaging (MEMRI) contrast agent: synthesis, toxicity (in vitro) and relaxivity (in vitro, in vivo) studies.
Bertin A; Steibel J; Michou-Gallani AI; Gallani JL; Felder-Flesch D
Bioconjug Chem; 2009 Apr; 20(4):760-7. PubMed ID: 19368343
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of diethylenetriaminepentaacetic acid-manganese(II) complexes modified by narrow molecular weight distribution of chitosan oligosaccharides as potential magnetic resonance imaging contrast agents.
Huang Y; Zhang X; Zhang Q; Dai X; Wu J
Magn Reson Imaging; 2011 May; 29(4):554-60. PubMed ID: 21277723
[TBL] [Abstract][Full Text] [Related]
19. Mn12 single-molecule magnet aggregates as magnetic resonance imaging contrast agents.
Wang Y; Li W; Zhou S; Kong D; Yang H; Wu L
Chem Commun (Camb); 2011 Mar; 47(12):3541-3. PubMed ID: 21327273
[TBL] [Abstract][Full Text] [Related]
20. A new magnetic resonance imaging contrast agent loaded into poly(lacide-co-glycolide) nanoparticles for long-term detection of tumors.
Rigaux G; Roullin VG; Cadiou C; Portefaix C; Van Gulick L; Bœuf G; Andry MC; Hoeffel C; Vander Elst L; Laurent S; Muller R; Molinari M; Chuburu F
Nanotechnology; 2014 Nov; 25(44):445103. PubMed ID: 25325295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
